This article is more than 5 years old. Information may no longer be current.

Quantel's Easyret photocoagulator approved in Japan

Issue: February 2018

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Easyret integrated 577 nm yellow photocoagulator has received Japanese market approval, according to a press release from Quantel Medical.

The Easyret is used to treat certain forms of macular edema and peripheral retinal pathologies, the release said.

“The Easyret’s ELBA fiber laser cavity delivers pure 577 nm yellow wavelength in a uniform laser spot profile, making it ideal for ophthalmic applications,” Jean-Marc Gendre, Quantel’s CEO, said in the release.

The device is already available in more than 50 countries, including the United States.